GFPT1
GFPT1 (glutamine--fructose-6-phosphate transaminase 1, also known as GFAT, GFA, GFAT1 and GFPT) is the first and rate-limiting enzyme of the hexosamine biosynthetic pathway. It catalyses the formation of glucosamine-6-phosphate and so controls the flux of glucose into this pathway. Browse Assay Genie's current range of GFPT1 research reagents below, or read on for the biology behind the target.
GFPT1 is the rate-limiting enzyme of the hexosamine biosynthetic pathway (HBP). It catalyses the formation of glucosamine-6-phosphate from fructose-6-phosphate and glutamine, and in doing so controls how much glucose is directed into the pathway. Activity is restrained by a feedback loop in which UDP-N-acetylglucosamine (UDP-GlcNAc), the pathway's end product, inhibits the enzyme.
Through its control of the HBP, GFPT1 regulates the availability of precursors for N-linked and O-linked protein glycosylation. It also fine-tunes metabolic fluctuations in UDP-GlcNAc and the effect of these on hyaluronan synthesis during tissue remodelling, and it modulates oscillation of the peripheral clock. Researchers working on glycosylation, nutrient sensing and metabolic regulation therefore study the GFPT1 protein as a point where glucose supply is coupled to downstream biosynthetic output.
The human GFPT1 gene belongs to the glutamine--fructose-6-phosphate transaminase family, and its product is classed as EC 2.6.1.16. The enzyme is also referred to as GFAT, GFA, GFAT1 or GFPT, and the previous gene name was glutamine-fructose-6-phosphate transaminase 1. Mouse and rat each have an orthologous gene, Gfpt1. A related family member, GFPT2, is also available as a research target.
GFPT1 is the first and rate-limiting enzyme of the hexosamine pathway, making it a central point for studying glucose flux into this route.
By controlling precursor availability, GFPT1 influences both N-linked and O-linked protein glycosylation.
GFPT1 fine-tunes UDP-GlcNAc fluctuations and their impact on hyaluronan synthesis during tissue remodelling.
Via the hexosamine pathway, GFPT1 modulates peripheral clock oscillation, linking metabolism to circadian timing.
GFPT1 is the rate-limiting enzyme of the hexosamine biosynthetic pathway. It converts fructose-6-phosphate and glutamine into glucosamine-6-phosphate, controlling glucose flux into the pathway. UDP-GlcNAc inhibits it by feedback, and it affects glycosylation precursor supply, hyaluronan synthesis and peripheral clock oscillation.
GFPT1 is also called GFAT, GFA, GFAT1 and GFPT. Its full HGNC name is glutamine--fructose-6-phosphate transaminase 1, and UniProt lists it as glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1. An earlier name was glutamine-fructose-6-phosphate transaminase 1.
Yes. Mouse and rat both carry an ortholog named Gfpt1, so the enzyme can be studied in common rodent models. GFPT2 is a related family member. As always, check the datasheet of any product for its validated reactivity.
GFPT2, the related member of the glutamine--fructose-6-phosphate transaminase family, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q06210; product specifications from Assay Genie datasheets.